Development of nomogram based on immune-related gene FGFR4 for advanced non-small cell lung cancer patients with sensitivity to immune checkpoint inhibitors

INTRODUCTION: Immune checkpoint inhibitors (ICIs) have become a frontier in the field of clinical technology for advanced non-small cell lung cancer (NSCLC). Currently, the predictive biomarker of ICIs mainly including the expression of PD-L1, TMB, TIICs, MMR and MSI-H. However, there are no officia...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Ren, Zhixuan, Yu, Bentong, Tang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788998/
https://www.ncbi.nlm.nih.gov/pubmed/33407583
http://dx.doi.org/10.1186/s12967-020-02679-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788998/
https://www.ncbi.nlm.nih.gov/pubmed/33407583
http://dx.doi.org/10.1186/s12967-020-02679-0

Ejemplares similares